logo
Plus   Neg
Share
Email

Sanofi Says FDA To Review Meningococcal Vaccine Candidate MenQuadfi

French pharma major Sanofi (SNYNF,SNY) announced Thursday that the U.S. Food and Drug Administration has accepted for review the Biologics License Application or BLA for MenQuadfi, a meningococcal vaccine candidate. The target action date for the FDA decision is April 25, 2020.

The company noted that the BLA is for MenQuadfi Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine candidate to help prevent meningococcal meningitis.

Sanofi's recently submitted BLA includes positive data from Phase II and Phase III clinical trials held in the U.S. to seek an indication for use of the vaccine in persons 2 years of age and older. If approved, MenQuadfi will be available in a fully liquid presentation.

The company has performed Phase II and Phase III trials in the U.S., the European Union, Asia and Latin America. Sanofi is conducting additional Phase III trials in these same regions and Africa.

MenQuadfi's safety and efficacy data have not yet been evaluated by any regulatory authority.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of EVERTEC, Inc. (EVTC) saw a rise in trading volume to 536 million on Friday, vs. average trading volume of 366 million. The electronic payments company has gained prominence, because of its unique focus on Latin America, where rising cash-to-card conversion is fueling growth for the electronic... Fast food giant McDonald's fired an Australian franchisee, who owns two of its restaurants, over a video that showed him and a companion making racist comments against Aborigines. The company took control of the restaurants in Victoria from Robert Vigors, who made the racist rants at the home of neighbor Robby Wirramanda, an Indigenous artist. The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS warned against certain chicken soup products imported from Canada due to misbranding and the presence of allergens. The warning letter was issued after the Canadian Food Inspection Agency or CFIA notified FSIS that Canada-based Canyon Creek Soup Co. Ltd. has recalled its chicken soup products.
Follow RTT
>